Aller au contenu principal
2023 conference-abstract

TSPO Mediates Tubulointerstitial Fibrosis and Kidney Inflammation After Unilateral Ureteral Obstruction

0Citations signalées, ce qui n’est pas une note de qualité
2Institutions déclarées
1Pays d’affiliation déclarés

Rattachement africain : hk. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

Background: Tubulointerstitial fibrosis is a hallmark of chronic kidney disease (CKD) and predicts progression to kidney failure. A better understanding of its pathogenetic mechanisms is required for designing novel and effective treatments for this irreversible pathological process. Translocator protein (TSPO), located on the outer mitochondrial membrane, is associated with renal tubular cell death and regeneration in acute kidney injury. However, the role of TSPO in progressive CKD remains unknown. Methods: Unilateral ureteral obstruction (UUO) or sham operation were performed on C57BL/6J mice to establish progressive tubulointerstitial fibrosis. TSPO antagonist PK11195 or vehicle was administrated daily to UUO mice for 7 days starting on the day of surgery. Kidneys were harvested for histology, inflammation and fibrosis. Results: Histopathologically, tubular damage induced by UUO was reversed by PK11195 treatment. Induction of TNF-α, CCL-2 and IL-1β mRNA in the UUO kidney was reduced in PK11195 group compared to vehicle control. UUO-induced collagen deposition, as demonstrated by Masson's Trichrome and Picrosirius Red staining, was decreased after PK11195 treatment, and immunohistochemical analysis further confirmed significant reduction of Col-1 and Col-3 expression. Furthermore, PK11195 treatment downregulated UUO-induced fibronectin, α-SMA, vimentin and TGF-β levels by Western blotting. Conclusions: We provided novel data to show that blockade of TSPO activity could alleviate kidney fibrosis and inflammation in murine UUO, suggesting that TSPO could play an important role in regulating progressive kidney disease. Funding: Health and Medical Research Fund (HMRF) of Hong Kong (grant no. 09202356); Hong Kong Society of Nephrology Research Grant 2022 Funding: Government Support - Non-U.S.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
TSPO Mediates Tubulointerstitial Fibrosis and Kidney Inflammation After Unilateral Ureteral Obstruction
Date Crossref
01/11/2023
Éditeur
Ovid Technologies (Wolters Kluwer Health)
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Ureteral procedures and complicationsKidney Stones and Urolithiasis Treatments

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.